Head-To-Head Review: Enovis (NYSE:ENOV) and Clover Health Investments (NASDAQ:CLOV)

Enovis (NYSE:ENOV) and Clover Health Investments (NASDAQ:CLOV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

Insider & Institutional Ownership

98.5% of Enovis shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 2.9% of Enovis shares are held by insiders. Comparatively, 23.5% of Clover Health Investments shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Enovis has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.44, suggesting that its share price is 144% more volatile than the S&P 500.

Profitability

This table compares Enovis and Clover Health Investments’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enovis	-49.92%	10.32%	4.57%
Clover Health Investments	-2.58%	-16.52%	-9.28%

Valuation & Earnings

This table compares Enovis and Clover Health Investments”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25 billion	0.62	-$1.18 billion	($19.88)	-1.22
Clover Health Investments	$1.92 billion	0.97	-$85.55 million	($0.12)	-29.58

Clover Health Investments has lower revenue, but higher earnings than Enovis. Clover Health Investments is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and price targets for Enovis and Clover Health Investments, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1	0	7	1	2.89
Clover Health Investments	1	3	1	0	2.00

Enovis presently has a consensus price target of $44.50, indicating a potential upside of 84.22%. Clover Health Investments has a consensus price target of $2.90, indicating a potential downside of 18.31%. Given Enovis’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Enovis is more favorable than Clover Health Investments.

Summary

Enovis beats Clover Health Investments on 9 of the 15 factors compared between the two stocks.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.